Skip to content
DataLookout
Menu

NCT06507930

The COMPASSION Study

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved 2 years later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Oct 1, 2026 to Oct 1, 2028
    • Eligibility criteria expanded, about 11 words
    • Study completion pushed from Mar 1, 2027 to Mar 1, 2029
  2. Notable Primary completion date: Sep 1, 2025 to Oct 1, 2026
    • Study completion date: Mar 1, 2026 to Mar 1, 2027
    v3
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 2025 to Sep 1, 2024
    • Site details revised
    v2
  4. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Proportion of Participant Intervention Completion
Timeframe: Up to 4 weeks

Arms and interventions

Usual Care CohortNo intervention

25 participants will complete study procedures as follows: * Introduction to study and survey by brief, verbal consent via phone call. * At 4-6 weeks: survey completion via email or phone.

Compassion CohortExperimental

25 participants will complete study procedures as follows: * Introduction to study and survey by brief, verbal consent via phone call. * At 4-6 weeks: survey completion via email or phone. * 4 weekly check-ins via Zoom or phone call with study team.

Other: Telehealth Hospice Visits

Sites

1 site in 1 country

  • Dana-Farber Cancer InstituteBoston, Massachusetts, United States